Einstein on Cancer: New Paper Explores Relativity and Aging

July 3, 2018 | Abe Rosenberg

As director of City of Hope's Division of Mathematical Oncology, Russell Rockne, Ph.D., spends his days building mathematical models to help us better understand how cancer works.

Continue Reading

Benjamin Djulbegovic, M.D., Ph.D., joins the Department of Supportive Care Medicine

June 8, 2018 | City of Hope

Benjamin Djulbegovic, M.D., Ph.D. is a professor and director of research in the Department of Supportive Care Medicine.

Stephen Forman, M.D., Inducted into AAP

May 30, 2018 | Michael Easterling

Stephen J. Forman, M.D., the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, has been inducted as a member of the Association of American Physicians.

Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work

January 12, 2018 | Letisia Marquez

Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.

Geriatric assessment guides treatment strategy for older adults with cancer

December 1, 2017 | City of Hope

Researchers developed a self-administered geriatric assessment to identify areas of vulnerability and guide interventions for older adults with cancer.

Renowned Cancer Researcher Named President of City of Hope National Medical Center and Physician-in-Chief of City of Hope

November 28, 2017 | City of Hope

Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief of City of Hope.

City of Hope’s Ravi Salgia, M.D., Ph.D., honored by the IACA

June 2, 2017 | Letisia Marquez

City of Hope’s Ravi Salgia, M.D., Ph.D., whose accomplishments as a medical oncologist and researcher have helped shape modern cancer medicine, was celebrated at ASCO by the Indo-American Cancer Association (IACA) for his contributions to the field.

Translational researcher Larry Kwak explores lymphoma therapy's frontier

May 30, 2015 | City of Hope Staff

Lymphoma expert Larry Kwak has plans to improve the vaccine-based immunotherapy for which he is known. CAR T cells hold promise.